Quantcast

Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

Your information is NEVER sold to a third party. 

Important Recall: 3 more heartburn meds are off the market

Advertisements
Share On Social Media
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  

This is your medical minute report of the week. According to at least 3 companies and U.S regulators, the following medications meant to treat heartburn have been recalled from the market.

Appco Pharma and Denton Pharma and Mylan are the three companies responsible for pulling their products. According to the FDA, those products include two generic forms of Zantac which have been found to contain the carcinogenic traces of NDMA. The generic forms of this medication may otherwise be known as ranitidine (Mylan’s is Nizatidine.)

The problem? The FDA says that they’ve found NDMA – the short-hand for N-Nitrosodimethylamine –  in all of the drugs listed. They’ve found traces of said carcinogen well beyond legal levels in the U.S. NDMA is and has been proven to be a carcinogenic agent in multiple animal species and is known to cause liver; lung, and multiple other forms of cancer.


Share On Social Media
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
See also  Report: Guards assigned to to watch Jeffrey Epstein grossly overworked
By Jacinda Marie Brown

Leave a Reply

Related Posts

No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.
Cookie Consent with Real Cookie Banner Skip to content